Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

41 search results for ‘*’

Manufacture Advanced Medicine

CGT Manufacturing Capacity: Battle of the CDMOs

| 2 min read

Capacity has been built for cell and gene therapy manufacturing, but will demand keep pace? CDMOs may face a battle for survival.


Business & Regulation Trends & Forecasts

Our Videos: The Greatest Hits

| 1 min read

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.

Business & Regulation Standards & Regulation

Video Interview: Claus Zieler of Astellas and EFPIA

| Stephanie Vine

Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe.

Manufacture Bioprocessing - Upstream & Downstream

Just – Evotec Biologics Expands in Europe

Find out more about a new continuous manufacturing facility opened by Just – Evotec Biologics in Toulouse, France.

Discovery & Development Contract Development Services

Redefining Sterile Manufacturing Standards with Kindeva

Milton Boyer and Dave Stevens delve into the company’s evolution and expertise in sterile manufacturing and drug delivery systems.

Manufacture Contract Manufacturing Services

Navigating Market Changes: Piramal Pharma's Growth and Key Industry Trends

| Rob Coker

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

Business & Regulation Trends & Forecasts

The Cell Preservation Society

Experts discuss the trends, challenges, and advantages in cryopreservation use for cell and gene therapies

Manufacture Advanced Medicine

Introducing a Regulatory Playbook for Gene Therapy

| Stephanie Vine

In this video interview, Courtney Silverthorn explains the inspiration behind a free regulatory playbook for gene therapy manufacturers.

Business & Regulation Business Practice

Video Interview: The High Costs of Advanced Therapies, Part 2

| Stephanie Vine

Cardinal Health’s Fran Gregory looks at innovative payment models for cell and gene therapies.

Business & Regulation Business Practice

Video Interview: The High Costs of Advanced Therapies, Part 1

| Stephanie Vine

Cardinal Health’s Fran Gregory talks about the high costs of cell and gene therapies, and what this means for payers.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker